NCT05502471View on ClinicalTrials.gov

Occludin and Zonulin in Attention-deficit/Hyperactivity Disorder

NACompletedINTERVENTIONAL
Enrollment

79

Participants

Timeline

Start Date

January 1, 2021

Primary Completion Date

June 1, 2021

Study Completion Date

June 1, 2021

Conditions
Attention-deficit/Hyperactivity Disorder
Interventions
DIAGNOSTIC_TEST

Zonulin

Serum zonulin level

DIAGNOSTIC_TEST

Occludin

Serum occludin level

Trial Locations (1)

Unknown

Ataturk University Hospital, Erzurum

All Listed Sponsors
lead

Ataturk University

OTHER

NCT05502471 - Occludin and Zonulin in Attention-deficit/Hyperactivity Disorder | Biotech Hunter | Biotech Hunter